4 completed. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 1 | Completed 1 |
Follow threonic acid: new trials by email Literature Review of threonic acid trials Research Report on threonic acid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of MMFS Dosages in Older Adults Low Dose MMFS-205-SR, High Dose MMFS-205-SR, Placebo - Anxiety, Depression | Phase 2 | Completed | Neurocentria, Inc. | 9 | 2018-07-23 | 2020-09-09 |
| Efficacy and Safety of MMFS in Early AD MMFS-205-SR, Placebo - Alzheimer Disease | Phase 2 | Completed | Neurocentria, Inc. | 10 | 2018-03-20 | 2020-09-09 |
| Magnesium Supplementation in People With XMEN Syndrome Magnesium L-threonate, Placebo, Intravenous (IV) magnesium sulfate (MgSO4) - XMEN | Phase 1 / Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 8 | 2016-05-17 | 2022-03-02 |
| L-Threonic Acid Magnesium Salt (L-TAMS) in ADHD L-Threonic Acid Magnesium Salt (L-TAMS) - Attention Deficit/Hyperactivity Disorder, ADHD | Phase 2 | Completed | Massachusetts General Hospital | 20 | 2016-03-01 | 2018-05-14 |
Alzheimer Disease (1) · Anxiety Disorders (1) · Attention Deficit Disorder with Hyperactivity (1) · Cognitive Dysfunction (1) · Depression (1) · Epstein-Barr Virus Infections (1) · Infections (1) · Neoplasms (1) · Primary Immunodeficiency Diseases (1) · Sleep Initiation and Maintenance Disorders (1)
Neurocentria, Inc. (2) · Massachusetts General Hospital (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (4)
Craig Surman, MD (1) · Donald Burkindine, MD (1) · Douglas W Scharre, MD (1) · Juan C Ravell Aumaitre, M.D. (1)